Succinimidyl PEG NHS, mPEG-NHS - ≥95%, MW 750 Da

Cat. No.: S164331
Disponibile su ordine
QUALITÀ & PUREZZA ≥95% MW 750 Da
Storage
Store at -20°C,Argon charged
Shipped In
Ice chest + Ice pads
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
100mg
S164331-100mg
—
2 Disponibile
51,11€
500mg
S164331-500mg
—
2 Disponibile
176,93€
Enter a quantity for the sizes you want to add.

Panoramica

N-hydroxylsuccinimide (NHS) functionalized polyethylene glycol (PEG-NHS) is an amino (-NH2) reactive PEG derivative that can be used to modify protein, peptide or any other surfaces with their available amino groups. NHS esters react with primary amine groups at pH 7~8.5 to form stable amide bonds.Compared to other PEG NHS ester derivatives, our succinimidyl carbonate (SC) functionalized mPEG-NHS offers superior reactivity and higher stability in aqueous solution. NHS esters react with deprotonated primary amines, therefore, the reaction requires neutral to basic pH values to proceed. Primary amines react with NHS esters by nucleophilic attack and NHS is released as a byproduct. Hydrolysis of the NHS-ester competes with the reaction in aqueous solution and increases with increasing pH.

Specifiche

Specifiche e purezza
≥95%, MW 750 Da
Meccanismi biochimici e fisiologici

Generally, a 10 to 50-fold molar excess of NHS PEG over the amount of amine-containing material results in sufficient conjugation.

Materials Required:

  • Conjugation buffer: Sodium bicarbonate 100 mM buffer, pH 8.5 or other amine-free buffer at pH 7-8.5.
  • PEG NHS stock solution: 100 mg in 1 mL conjugation buffer.
  • Washing solution: Distilled water or any aqueous buffer.

Reaction Steps:

Dissolve targeted materials in conjugation buffer. Estimate the concentration of primary amine groups on the targeted materials. Add NHS PEG stock solution to the targeted conjugation materials with the final concentration keep at least 10 mg/mL. 10~50 molar excess of PEG NHS needed for optimal conjugation; Allow mixture agitates at room temperature for 30~60 min at room temperature or 2 hours at 4 0C. Conjugates can be purified either by size exclusion chromatography or dialysis.

Condizioni di conservazione di stoccaggio
Store at -20°C,Argon charged
Spedito in
Ice chest + Ice pads
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Purezza
≥95%

Dati avanzati

Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

4 results found

Lot NumberCertificate TypeDataOggetto
K2222646K2222646Certificate of AnalysisSep 24, 2025 S164331
K2222738K2222738Certificate of AnalysisSep 24, 2025 S164331
K2104179K2104179Certificate of AnalysisAug 22, 2024 S164331
K2104180K2104180Certificate of AnalysisAug 22, 2024 S164331
Proprietà chimiche e fisiche
SolubilitàOff-white/white solid or viscous liquid depends on molecule weight;Soluble in regular aqeous solution as well as most organic solvents;
SensibilitàMoisture sensitive
Domande frequenti e articoli
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

General bioconjugation protocol (literature example; adjust to system)

  1. Prepare solutions
  • Dissolve the amine-bearing target (e.g., protein) in phosphate or HEPES buffer, pH 7.4–8.0, 1–5 mg/mL. Keep on ice if stability is a concern.
  • Prepare a fresh stock of mPEG–NHS in anhydrous DMSO or DMF (e.g., 50–200 mM). Work quickly, under dry atmosphere.
  1. Conjugation
  • Add mPEG–NHS stock dropwise to the target solution with gentle stirring to reach the desired molar ratio (e.g., 5–20 eq per accessible amine or 2–10 eq per protein, depending on desired modification level).
  • Incubate 30–60 min at 4–25°C. Maintain pH 7.4–8.0. Avoid prolonged exposure to minimize hydrolysis.
  1. Quench and purify
  • Quench remaining active ester with 10–50 mM ethanolamine, 10–15 min at room temperature (optional if downstream steps remove unreacted reagent).
  • Purify by size-exclusion chromatography, desalting columns, dialysis, or ultrafiltration (cutoff selected to retain the conjugate).
  1. Characterization
  • Proteins: Analyze by SDS-PAGE (band shift), SEC (hydrodynamic size), and MS if feasible. For small molecules/peptides: MS and NMR.

Notes

  • Avoid amine-containing buffers (Tris/glycine). Keep solutions oxygen- and moisture-limited. For surfaces/nanomaterials, pre-functionalize with amines and use dry organic media or mixed solvent systems for uniform coverage.
Biological Roles

Applicability

  • This product is a synthetic coupling reagent for laboratory research. It does not possess inherent biological activity in the sense of a biomolecule or drug. The notes below describe the roles of PEGylation in biochemical systems (literature/general), not medical claims.

Literature context

  • PEGylation: Covalent attachment of poly(ethylene glycol) chains to biomolecules is widely used to modulate biophysical properties — increasing hydrodynamic size, reducing nonspecific adsorption, and enhancing solubility. PEG can sterically shield surfaces, diminishing protein–protein or protein–surface interactions.
  • Protein conjugation: Attaching mPEG to lysines or the N-terminus can alter isoelectric point and decrease proteolysis or aggregation in vitro. Multi-PEGylation can broaden size distribution; controlled stoichiometry and site-selective strategies are often preferred for functional studies.
  • Materials and interfaces: PEG grafting creates antifouling layers that resist biofouling and reduce protein adsorption in analytical devices and biosensors.

Important

  • Any discussion of pharmacology, therapeutic benefit, or in vivo outcomes is outside the scope of this listing. This item is for research use only. Users should design experiments with appropriate controls to assess how PEGylation affects their specific system’s activity and binding.
Buffer Applications

Relevance

  • mPEG–NHS is not itself a buffer. However, buffer choice is central to successful NHS–amine coupling. Below are general, literature-based buffer guidelines for conjugations.

Recommended buffers (literature)

  • Phosphate or HEPES, pH 7.2–8.0: Balance between reaction rate and NHS stability; typical ionic strength 50–150 mM.
  • Sodium bicarbonate/carbonate, pH 8.0–8.5: Faster coupling but increased hydrolysis; use promptly and keep cool if biomolecules are sensitive.
  • Additives: 0–10% DMSO/DMF can assist solubility of higher-MW PEG without severely impacting biomolecule stability (verify compatibility).

Avoid

  • Tris, glycine, ethanolamine, or other primary/secondary amine-containing buffers, which compete with the intended amine target and quench the NHS ester.
  • High concentrations of nucleophiles (e.g., azide is generally acceptable; primary amines are not).

Practical tips

  • Pre-adjust pH at working temperature; maintain narrow pH window during conjugation.
  • Filter buffers (0.22 µm) and degas if foaming or oxidation is a concern; keep solutions cold until use to slow hydrolysis.
  • Prepare fresh buffer on the day of use when precise pH and low nucleophile background are critical.
Green Alternatives

Context

  • mPEG–NHS is widely used for efficient amine acylation but relies on moisture-sensitive NHS chemistry and often requires polar aprotic solvents (DMF/DMSO). Greener choices aim to reduce solvent hazards, improve aqueous compatibility, and extend pot-life to reduce waste.

Options and trade-offs (literature)

  • mPEG–TFP ester (tetrafluorophenyl): Typically more hydrolytically stable than NHS, allowing lower excess and less waste; however, fluorinated leaving group poses persistence concerns and may require similar solvents.
  • mPEG–Carbonate (pNPC or pNP): Reacts with amines under milder conditions and can be more stable in storage; reaction rates may be slower, and byproduct pNP bears its own hazard profile.
  • Aqueous-first protocols: Use of buffered aqueous systems with minimal cosolvent (≤10–20% DMSO) reduces reliance on neat DMF/DMSO; requires careful control of pH and faster execution to limit hydrolysis.
  • Enzyme-mediated coupling: For site-specific PEGylation (e.g., transglutaminase or sortase strategies), eliminates activated esters; greener but requires engineered handles and enzymes.

Mini comparison (general)

  • NHS ester: Fast, well-understood; sensitive to water; common solvents DMSO/DMF.
  • TFP ester: More stable; potentially less hydrolysis; similar solvent use.
  • Carbonate: Often greener profile; slower kinetics; different selectivity.

Implementation tips

  • Use anhydrous stock solutions, minimize excess reagent, and adopt aqueous-compatible conditions to reduce solvent volumes and waste.
Pharmaceutical Uses

Scope and limitations

  • No therapeutic or clinical claims are made. This product is sold for research use only. The information below describes general formulation roles of PEG materials (literature) and is not specific to this catalog item.

General formulation roles of PEGs (literature)

  • Excipient functions: Poly(ethylene glycol)s are employed as solubilizers, viscosity modifiers, plasticizers, and surface-shielding agents in dosage forms and device coatings.
  • Conjugation intermediates: Activated PEGs (such as NHS end-groups) are used during process development to explore protein/peptide conjugates, diagnostics, and device surface modifications. Process-grade specifications, GMP controls, and traceability are required for any regulated use.

Considerations for process translation

  • End-group fidelity and residual impurity limits (free NHS, residual solvents, heavy metals) must be tightly controlled; these are batch- and vendor-specific.
  • Analytical release: SEC/GPC for MW and PDI, NMR/IR for identity, LC for residual NHS/p-NHS, and KF for water are common.

Item-specific status

  • Grade/purity and pharmacopeia status for this item are not specified; refer to CoA/Spec Sheet. For any use beyond research, obtain appropriate grade material and regulatory documentation from the manufacturer.
Physical Properties

Item-specific facts (from Product Data)

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

General/literature properties (typical for mPEG–NHS)

  • Physical state: Depending on MW, mPEG–NHS may be a waxy solid, semi-solid, or viscous oil; higher MWs tend to be white, free-flowing solids.
  • Solubility: Freely soluble in polar aprotic solvents such as anhydrous DMF and DMSO; often soluble or dispersible in aqueous buffers, with hydrolysis of the NHS ester occurring over time (faster at higher pH).
  • Hygroscopicity: PEG chains are hygroscopic; NHS esters are moisture-sensitive and hydrolyze to the corresponding carboxylate.
  • Partitioning: PEG backbones confer hydrophilicity; overall amphiphilicity depends on chain length. LogP is not a single value due to polydispersity and polymeric nature.
  • Thermal behavior: NHS esters can decompose/hydrolyze upon prolonged heating; gentle handling at ambient or lower temperatures is typical. Avoid elevated temperatures during storage or prolonged processing.
  • pKa/UV: Not typically characterized by a single pKa or sharp UV cutoff due to polymeric character; NHS leaving group absorbs weakly in the near-UV, but quantitative values vary by solvent and concentration.

Important

  • For any numerical specifications (density, RI, mp/bp, water content), this catalog entry does not list values. Refer to the CoA/Spec Sheet for batch-specific data if available.
Quality and Grades

Item-specific facts (from Product Data)

  • Grade/purity: Not specified for this item; refer to CoA/Spec Sheet.

How to interpret grades for mPEG–NHS (general guidance)

  • PEGylation-grade/bioconjugation-grade: Typically indicates low residual solvents, controlled polydispersity, and low levels of reactive impurities (free NHS, acids) that could compete in amide formation.
  • Anhydrous quality: Critical for active esters; low water content extends shelf-life and maximizes coupling efficiency. Suppliers may package under inert gas with desiccant to maintain activity.
  • Analytical controls: Relevant tests include NMR for end-group fidelity, titration of active ester content, SEC/GPC for Mn/Mw and PDI, and residual solvents/byproducts by GC/MS or LC.
  • Stabilizers: Not specified for this item. Some vendors avoid stabilizers to keep conjugation clean; others may include desiccants only. Check the CoA/SDS to confirm.

What to check on the CoA for your batch

  • Average molecular weight (Mn or nominal MW) and PDI, end-group functionality (% active NHS), residual solvent, water content (Karl Fischer), and identity/purity by NMR/IR/SEC.
  • Storage statements and retest/expiry dating under sealed, inert conditions at −20°C.

Practical quality tips

  • Open only under dry atmosphere. If activity matters (e.g., protein PEGylation), perform a quick active ester assay or small-scale test conjugation before committing valuable biomaterial.
Reaction and Applications

Scope (literature)

  • Primary application: Chemoselective acylation of primary amines to form amide bonds, enabling PEGylation of proteins (lysine residues or N-termini), peptides, antibodies, nanoparticles, and amine-functionalized surfaces.
  • Mechanism: Nucleophilic attack of the amine on the NHS ester carbonyl forms a tetrahedral intermediate; collapse expels N-hydroxysuccinimide, yielding a stable amide. Mild base (pH 7.4–8.5) increases amine nucleophilicity.

Use cases

  • Protein/peptide PEGylation: Enhances solubility, reduces aggregation and nonspecific interactions, modulates hydrodynamic radius, and can shield surface charge. Site selectivity can be tuned via pH, stoichiometry, and protein engineering.
  • Surface modification: Grafting to amine-terminated self-assembled monolayers, polymers, and nanoparticles to impart antifouling and stealth properties.
  • Material conjugation: Attachment to amine-bearing dyes, small molecules, or linkers to create PEG spacers in diagnostics and research tools.

Practical notes

  • Hydrolysis competition: NHS ester half-life shortens with increased pH and temperature; prepare fresh solutions, exclude moisture, and minimize reaction times. Ice-bath set-up for sensitive biomolecules is common.
  • Buffer selection: Avoid Tris/glycine; favor phosphate, HEPES, or bicarbonate. Include salts (e.g., 100–150 mM NaCl) if needed for protein stability.
  • Stoichiometry: Typical protein conjugations use 2–50 molar equivalents relative to accessible amines; optimize empirically to balance activity retention with desired PEGylation level.
  • Quenching: Unreacted NHS ester can be quenched with ethanolamine after conjugation to cap residual activity.
Reaction Conditions

General, literature-based guidance (optimize per system)

  • Solvent systems: Anhydrous DMSO or DMF stock (5–100 mM), added to buffered aqueous solutions to a final cosolvent fraction of 0–20% v/v. Fully aqueous coupling is possible for low-MW PEGs but increases hydrolysis.
  • pH: 7.2–8.5. Near pH 8.0 often provides a good balance between amine reactivity and NHS stability. Avoid pH > 9 unless rapid reaction and short exposure are intended.
  • Temperature: 4–25°C. Lower temperatures slow hydrolysis and can preserve biomolecule activity; room temperature accelerates coupling.
  • Time: 15 min to 2 h typical for proteins and small molecules; monitor progress and avoid prolonged incubations that favor hydrolysis.
  • Stoichiometry: 2–50 eq vs. amine for biomolecules; 1.1–2.0 eq for small-molecule amines. Excess drives conversion but increases risk of multi-PEGylation on proteins.
  • Additives: Sodium chloride (up to 150 mM) can stabilize proteins; avoid primary-amine buffers. Optional catalysts like DMAP are generally avoided in bioconjugation contexts.
  • Workup: Quench residual NHS ester with ethanolamine or glycine after the desired reaction time (note: quench after removing valuable amine-bearing target if selectivity is needed). Purify by SEC (proteins), dialysis, spin filtration, or precipitation depending on system.

Notes

  • Hydrolysis half-life varies with pH, temperature, and solvent; prepare fresh solutions immediately before use and minimize headspace moisture.
Safety and Handling

Item-specific facts (from Product Data)

  • Storage conditions: Store at −20°C, Argon charged (moisture/oxygen exclusion). Shipped on ice (ice chest + ice pads).
  • Research use: For research use only.
  • GHS information (signal word, hazard statements, pictograms, classification): Not specified for this item; refer to SDS.

General safety guidance for NHS-activated PEGs (literature, not a specification)

  • Hazards: NHS esters are irritants; contact with skin, eyes, and respiratory tract should be avoided. PEG backbones are generally considered of low acute toxicity, but dusts/aerosols can be irritating.
  • PPE: Use lab coat, safety glasses/goggles, and appropriate chemically resistant gloves (e.g., nitrile). Handle powders/solid granules in a fume hood to minimize inhalation and moisture exposure.
  • Incompatibilities: Avoid moisture, strong bases, and nucleophiles (amines, alcohols) during storage and handling. NHS esters hydrolyze in water, especially at pH > 7.
  • First aid (overview): In case of contact, rinse affected area with plenty of water for at least 15 minutes. If inhaled, move to fresh air. If ingested, rinse mouth and seek medical advice. Always follow your institution’s emergency procedures.
  • Spill management: Avoid creating dust; collect with inert absorbent under dry conditions. Dispose of in accordance with local regulations.

Authoritative source

  • Always consult and follow the item-specific SDS for definitive hazard classification and response measures.
Solvent Selection

Applicability

  • Suited for anhydrous polar aprotic solvents and mildly basic aqueous buffers during conjugation. Moisture sensitivity dictates solvent choice and handling.

General/literature guidance

  • Polar aprotic: Anhydrous DMF or DMSO dissolve most mPEG–NHS materials across a wide MW range and are compatible with amide-forming reactions. These are commonly used to prepare stock solutions for immediate dilution into buffer.
  • Aqueous buffers: For bioconjugation to amines, buffers at pH 7.2–8.5 (e.g., phosphate, HEPES, bicarbonate) are typical. Higher pH accelerates reaction but also hydrolysis; pH 7.4–8.0 often balances rate and stability.
  • Avoid: Buffers containing primary/secondary amines (Tris, glycine) or high concentrations of competing nucleophiles. Minimize organic alcohols that can transesterify.
  • Co-solvent use: 5–20% DMSO/DMF in buffer can aid solubility for higher-MW PEG while maintaining acceptable reaction rates. Verify target biomolecule tolerance to cosolvent.
  • Dielectric/polarity context: The PEG backbone ensures miscibility with many polar media; the NHS end-group prefers neutral to slightly basic, low-nucleophile environments for controlled coupling.

Selection tips

  • Choose DMF when maximum solvation and rapid dissolution are required; choose DMSO when biological compatibility on dilution is prioritized. For sensitive proteins, pre-dissolve in anhydrous DMSO, then add dropwise into buffered protein solutions with gentle mixing.
Storage and Reconstitution

Item-specific facts (from Product Data)

  • Storage conditions: Store at −20°C, Argon charged.
  • Shipping: Ice chest + ice pads.

General handling and reconstitution (literature/good practice)

  • Moisture protection: NHS esters are moisture-sensitive. Keep container tightly closed under inert gas with desiccant. Allow vials to warm to room temperature in a desiccator before opening to prevent condensation.
  • Aliquoting: If repeated use is expected, divide into single-use aliquots under dry atmosphere (e.g., glovebox or dry N2/argon purge) to minimize freeze–thaw and moisture uptake.
  • Reconstitution: Dissolve immediately before use in anhydrous DMSO or DMF to make a concentrated stock. Use dried glassware and low-moisture syringes. Optionally filter through a dry 0.2 µm PTFE filter for particle removal.
  • Aqueous use: After dilution into buffer (pH 7.2–8.5), proceed promptly with conjugation; do not store aqueous solutions due to hydrolysis.
  • Stability: Working solutions are short-lived; prepare fresh each session. Avoid prolonged exposure to light and elevated temperatures.
  • Disposal: Quench residues with ethanolamine or allow complete hydrolysis, then dispose according to institutional and local regulations.

Documentation

  • For batch-specific stability, retest dates, and any additional storage instructions, consult the item’s CoA and SDS.
Structure and Identity

Item-specific facts (from Product Data)

  • Product name: Succinimidyl PEG NHS, mPEG-NHS (SKU: S164331)
  • CAS: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES / InChIKey / CID: Not specified for this item; refer to CoA/Spec Sheet.

General structural description (literature)

  • mPEG-NHS denotes a methoxy-terminated poly(ethylene glycol) bearing an N-hydroxysuccinimide (NHS) active ester at the opposite end. The PEG chain length (and thus MW) is typically polydisperse unless otherwise specified.
  • Key functional groups: an activated carboxylate ester in a 5-membered succinimide ring (NHS ester), a terminal methoxy group (–OCH3), and a repeating ethylene glycol backbone –[CH2–CH2–O]n–.
  • 2D structure in words: A linear PEG chain begins at a methoxy cap, extends through n ethylene glycol repeats, and terminates in a carbonyl bearing an NHS active ester (a cyclic imide with two carbonyls). No stereocenters are present in the repeating unit; the polymer is flexible and amphiphilic.
  • Reactive handle: The NHS ester is primed to acylate primary amines to form stable amide bonds, releasing N-hydroxysuccinimide as the leaving group.

Notes

  • Exact n (degree of polymerization) and polydispersity index determine the average MW and are supplier/batch specific. Consult the CoA for precise identity metrics for this catalog item.
Synthetic Utility

Functional group strategy (literature)

  • Electrophile: The NHS ester is a classic activated carboxyl derivative, enabling efficient formation of amide bonds with primary amines under mild, near-neutral conditions.
  • Linker/spacer: The PEG segment serves as a hydrophilic, flexible spacer to distance functional domains, reduce steric hindrance, and improve solubility of hydrophobic moieties.

Applications

  • Bioconjugation: Installation of PEG onto lysine-bearing biomolecules or onto amine-terminated small molecules to tune hydrodynamic size and solubility.
  • Materials chemistry: Coupling to amine-functional polymers, particles, and surfaces to introduce non-fouling character or to provide a handle for subsequent chemistries (e.g., further coupling via the methoxy terminus remains inert, while alternate variants may bear orthogonal handles).
  • Multistep synthesis: mPEG–NHS can be used to cap or mask amines, modulate chromatographic behavior, or introduce PEG chains as solubilizing tags in synthetic sequences.

Strategic notes

  • Chemoselectivity: Primary amines react preferentially; secondary amines react sluggishly. Adjust pH and stoichiometry to limit over-PEGylation.
  • Orthogonality: Combine NHS chemistry with orthogonal conjugation handles (e.g., azide–alkyne click, maleimide–thiol) by selecting appropriately functionalized PEG variants when needed.
  • Analysis: Verify coupling by MS (for small molecules/peptides), SEC (proteins), or colorimetric assays for residual NHS; NMR can confirm end-group consumption for model systems.
Target Specificity

Not applicable to this reagent.

  • This product is a general amine-reactive coupling reagent and does not possess biological target specificity (no antigen/epitope, clone, isotype, or species reactivity). Use is driven by chemical reactivity toward primary amines rather than binding selectivity.

Domande frequenti

What is the purity of this product?
This product is supplied at ≥95% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at ?20 °C under argon. It is supplied under an argon blanket; reseal under inert gas after each use.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.